CA2727126A1 - Vaccins administres par voie nasale utilisant le ciblage nalt a detection multiple et des sequences de transport de polypeptide phagocytaire - Google Patents

Info

Publication number

CA2727126A1

CA2727126A1 CA2727126A CA2727126A CA2727126A1 CA 2727126 A1 CA2727126 A1 CA 2727126A1 CA 2727126 A CA2727126 A CA 2727126A CA 2727126 A CA2727126 A CA 2727126A CA 2727126 A1 CA2727126 A1 CA 2727126A1

Authority

CA

Canada

Prior art keywords

cells

vaccine

vaccines

phage

phages

Prior art date

2007-06-08

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Abandoned

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 229960005486 vaccine Drugs 0.000 title claims abstract description 447
• 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 203
• 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 189
• 229920001184 polypeptide Polymers 0.000 title claims abstract description 185
• 230000000242 pagocytic effect Effects 0.000 title claims abstract description 35
• 210000004027 cell Anatomy 0.000 claims abstract description 403
• 238000012360 testing method Methods 0.000 claims abstract description 143
• 238000012216 screening Methods 0.000 claims abstract description 139
• 241000700605 Viruses Species 0.000 claims abstract description 134
• 230000000890 antigenic effect Effects 0.000 claims abstract description 54
• 230000028993 immune response Effects 0.000 claims abstract description 50
• 101710132601 Capsid protein Proteins 0.000 claims abstract description 48
• 101710094648 Coat protein Proteins 0.000 claims abstract description 48
• 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims abstract description 48
• 101710125418 Major capsid protein Proteins 0.000 claims abstract description 48
• 101710141454 Nucleoprotein Proteins 0.000 claims abstract description 48
• 101710083689 Probable capsid protein Proteins 0.000 claims abstract description 48
• 210000000612 antigen-presenting cell Anatomy 0.000 claims abstract description 41
• 230000001413 cellular effect Effects 0.000 claims abstract description 35
• 210000002865 immune cell Anatomy 0.000 claims abstract description 34
• 102000002689 Toll-like receptor Human genes 0.000 claims abstract description 29
• 108020000411 Toll-like receptor Proteins 0.000 claims abstract description 29
• 239000002245 particle Substances 0.000 claims description 170
• 108090000623 proteins and genes Proteins 0.000 claims description 154
• 238000000034 method Methods 0.000 claims description 143
• 102000004169 proteins and genes Human genes 0.000 claims description 92
• 241001465754 Metazoa Species 0.000 claims description 87
• 210000000987 immune system Anatomy 0.000 claims description 72
• 108091007433 antigens Proteins 0.000 claims description 65
• 102000036639 antigens Human genes 0.000 claims description 65
• 239000000427 antigen Substances 0.000 claims description 64
• 230000001717 pathogenic effect Effects 0.000 claims description 62
• 238000002360 preparation method Methods 0.000 claims description 61
• 210000000680 phagosome Anatomy 0.000 claims description 60
• 230000000694 effects Effects 0.000 claims description 57
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 50
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 49
• 201000010099 disease Diseases 0.000 claims description 39
• 238000004519 manufacturing process Methods 0.000 claims description 32
• 108010052285 Membrane Proteins Proteins 0.000 claims description 30
• 102000018697 Membrane Proteins Human genes 0.000 claims description 30
• 210000003527 eukaryotic cell Anatomy 0.000 claims description 23
• 230000000813 microbial effect Effects 0.000 claims description 21
• 230000003612 virological effect Effects 0.000 claims description 20
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 19
• 241000724791 Filamentous phage Species 0.000 claims description 16
• 230000015572 biosynthetic process Effects 0.000 claims description 16
• 238000003780 insertion Methods 0.000 claims description 15
• 230000037431 insertion Effects 0.000 claims description 15
• 208000035475 disorder Diseases 0.000 claims description 10
• 210000003563 lymphoid tissue Anatomy 0.000 claims description 9
• 230000003308 immunostimulating effect Effects 0.000 claims description 8
• 108010067390 Viral Proteins Proteins 0.000 claims description 4
• 230000003834 intracellular effect Effects 0.000 claims description 4
• 210000003722 extracellular fluid Anatomy 0.000 claims description 2
• 210000002540 macrophage Anatomy 0.000 abstract description 128
• 244000052769 pathogen Species 0.000 abstract description 63
• 238000002823 phage display Methods 0.000 abstract description 42
• 230000003389 potentiating effect Effects 0.000 abstract description 23
• 238000012545 processing Methods 0.000 abstract description 19
• 210000004400 mucous membrane Anatomy 0.000 abstract description 12
• 108020004414 DNA Proteins 0.000 description 118
• 210000001519 tissue Anatomy 0.000 description 99
• 102000005962 receptors Human genes 0.000 description 98
• 108020003175 receptors Proteins 0.000 description 98
• 230000004044 response Effects 0.000 description 93
• 235000018102 proteins Nutrition 0.000 description 91
• 230000008569 process Effects 0.000 description 77
• 239000002671 adjuvant Substances 0.000 description 66
• 239000000203 mixture Substances 0.000 description 53
• 230000032258 transport Effects 0.000 description 52
• 239000008280 blood Substances 0.000 description 51
• 239000012528 membrane Substances 0.000 description 49
• 210000004379 membrane Anatomy 0.000 description 48
• 239000013598 vector Substances 0.000 description 48
• 241000282414 Homo sapiens Species 0.000 description 47
• 210000004369 blood Anatomy 0.000 description 47
• 230000008782 phagocytosis Effects 0.000 description 44
• 238000012384 transportation and delivery Methods 0.000 description 44
• 206010057249 Phagocytosis Diseases 0.000 description 43
• CTMZLDSMFCVUNX-VMIOUTBZSA-N cytidylyl-(3'->5')-guanosine Chemical class O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=C(C(N=C(N)N3)=O)N=C2)O)[C@@H](CO)O1 CTMZLDSMFCVUNX-VMIOUTBZSA-N 0.000 description 38
• 210000001616 monocyte Anatomy 0.000 description 38
• 241000699670 Mus sp. Species 0.000 description 37
• 238000011160 research Methods 0.000 description 37
• 206010028980 Neoplasm Diseases 0.000 description 36
• 241000588724 Escherichia coli Species 0.000 description 34
• 201000011510 cancer Diseases 0.000 description 34
• 230000006870 function Effects 0.000 description 34
• 238000013459 approach Methods 0.000 description 32
• 241000894006 Bacteria Species 0.000 description 30
• 241000282412 Homo Species 0.000 description 28
• 102000053602 DNA Human genes 0.000 description 27
• 210000001744 T-lymphocyte Anatomy 0.000 description 27
• 210000003719 b-lymphocyte Anatomy 0.000 description 26
• 210000002569 neuron Anatomy 0.000 description 26
• 238000009739 binding Methods 0.000 description 25
• 230000001537 neural effect Effects 0.000 description 24
• 150000001875 compounds Chemical class 0.000 description 23
• 239000003446 ligand Substances 0.000 description 23
• 210000000956 olfactory bulb Anatomy 0.000 description 23
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 23
• 230000027455 binding Effects 0.000 description 22
• 239000007788 liquid Substances 0.000 description 22
• 210000000265 leukocyte Anatomy 0.000 description 21
• 239000013612 plasmid Substances 0.000 description 21
• 241001515965 unidentified phage Species 0.000 description 21
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 20
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 20
• 239000002953 phosphate buffered saline Substances 0.000 description 20
• 239000003814 drug Substances 0.000 description 19
• 239000000835 fiber Substances 0.000 description 19
• 208000015181 infectious disease Diseases 0.000 description 19
• 241000894007 species Species 0.000 description 19
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
• 238000006243 chemical reaction Methods 0.000 description 18
• 239000003153 chemical reaction reagent Substances 0.000 description 18
• 239000010410 layer Substances 0.000 description 18
• 210000001539 phagocyte Anatomy 0.000 description 17
• 230000000172 allergic effect Effects 0.000 description 16
• 208000010668 atopic eczema Diseases 0.000 description 16
• 238000011161 development Methods 0.000 description 16
• MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 16
• 238000011534 incubation Methods 0.000 description 16
• 230000001404 mediated effect Effects 0.000 description 16
• 210000003800 pharynx Anatomy 0.000 description 16
• 230000004913 activation Effects 0.000 description 15
• 230000018109 developmental process Effects 0.000 description 15
• 239000012634 fragment Substances 0.000 description 15
• 230000002068 genetic effect Effects 0.000 description 15
• 206010022000 influenza Diseases 0.000 description 15
• 239000002609 medium Substances 0.000 description 15
• 210000003695 paranasal sinus Anatomy 0.000 description 15
• 102000004190 Enzymes Human genes 0.000 description 14
• 108090000790 Enzymes Proteins 0.000 description 14
• 241000124008 Mammalia Species 0.000 description 14
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
• 210000004556 brain Anatomy 0.000 description 14
• 230000007246 mechanism Effects 0.000 description 14
• 239000007922 nasal spray Substances 0.000 description 14
• 238000012552 review Methods 0.000 description 14
• 210000003497 sciatic nerve Anatomy 0.000 description 14
• 239000003053 toxin Substances 0.000 description 14
• 231100000765 toxin Toxicity 0.000 description 14
• 108700012359 toxins Proteins 0.000 description 14
• 241000700159 Rattus Species 0.000 description 13
• 102000008235 Toll-Like Receptor 9 Human genes 0.000 description 13
• 108010060818 Toll-Like Receptor 9 Proteins 0.000 description 13
• 239000000872 buffer Substances 0.000 description 13
• 239000003795 chemical substances by application Substances 0.000 description 13
• 238000001727 in vivo Methods 0.000 description 13
• 210000000440 neutrophil Anatomy 0.000 description 13
• 229940046166 oligodeoxynucleotide Drugs 0.000 description 13
• 210000002966 serum Anatomy 0.000 description 13
• 210000004872 soft tissue Anatomy 0.000 description 13
• 229940046168 CpG oligodeoxynucleotide Drugs 0.000 description 12
• 239000002202 Polyethylene glycol Substances 0.000 description 12
• 229920001223 polyethylene glycol Polymers 0.000 description 12
• 239000000243 solution Substances 0.000 description 12
• 239000006228 supernatant Substances 0.000 description 12
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 11
• 241000251539 Vertebrata <Metazoa> Species 0.000 description 11
• 125000000539 amino acid group Chemical group 0.000 description 11
• 150000001413 amino acids Chemical class 0.000 description 11
• 229960000723 ampicillin Drugs 0.000 description 11
• AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 11
• 230000001580 bacterial effect Effects 0.000 description 11
• 238000005516 engineering process Methods 0.000 description 11
• 239000012894 fetal calf serum Substances 0.000 description 11
• 239000000499 gel Substances 0.000 description 11
• 229940088597 hormone Drugs 0.000 description 11
• 239000005556 hormone Substances 0.000 description 11
• 238000012750 in vivo screening Methods 0.000 description 11
• 239000000126 substance Substances 0.000 description 11
• 230000008685 targeting Effects 0.000 description 11
• 108020004705 Codon Proteins 0.000 description 10
• 102000004127 Cytokines Human genes 0.000 description 10
• 108090000695 Cytokines Proteins 0.000 description 10
• 239000004098 Tetracycline Substances 0.000 description 10
• 230000005875 antibody response Effects 0.000 description 10
• 230000008901 benefit Effects 0.000 description 10
• 238000004113 cell culture Methods 0.000 description 10
• 230000001976 improved effect Effects 0.000 description 10
• 210000001165 lymph node Anatomy 0.000 description 10
• 239000000463 material Substances 0.000 description 10
• 239000008188 pellet Substances 0.000 description 10
• 229960002180 tetracycline Drugs 0.000 description 10
• 208000024827 Alzheimer disease Diseases 0.000 description 9
• 102000009016 Cholera Toxin Human genes 0.000 description 9
• 108010049048 Cholera Toxin Proteins 0.000 description 9
• 101500027983 Rattus norvegicus Octadecaneuropeptide Proteins 0.000 description 9
• 239000002585 base Substances 0.000 description 9
• 230000001159 endocytotic effect Effects 0.000 description 9
• 239000012530 fluid Substances 0.000 description 9
• 210000002443 helper t lymphocyte Anatomy 0.000 description 9
• 230000037361 pathway Effects 0.000 description 9
• 239000000813 peptide hormone Substances 0.000 description 9
• 238000000746 purification Methods 0.000 description 9
• 229930101283 tetracycline Natural products 0.000 description 9
• 235000019364 tetracycline Nutrition 0.000 description 9
• 150000003522 tetracyclines Chemical class 0.000 description 9
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
• 108010090849 Amyloid beta-Peptides Proteins 0.000 description 8
• 102000013455 Amyloid beta-Peptides Human genes 0.000 description 8
• 108010041986 DNA Vaccines Proteins 0.000 description 8
• 229940021995 DNA vaccine Drugs 0.000 description 8
• 206010020751 Hypersensitivity Diseases 0.000 description 8
• 238000004458 analytical method Methods 0.000 description 8
• 230000002238 attenuated effect Effects 0.000 description 8
• 210000005013 brain tissue Anatomy 0.000 description 8
• 210000000170 cell membrane Anatomy 0.000 description 8
• 238000005119 centrifugation Methods 0.000 description 8
• 210000001787 dendrite Anatomy 0.000 description 8
• 210000004443 dendritic cell Anatomy 0.000 description 8
• 230000002708 enhancing effect Effects 0.000 description 8
• 238000009472 formulation Methods 0.000 description 8
• 230000014509 gene expression Effects 0.000 description 8
• 238000003306 harvesting Methods 0.000 description 8
• 238000002372 labelling Methods 0.000 description 8
• 239000012139 lysis buffer Substances 0.000 description 8
• 238000002156 mixing Methods 0.000 description 8
• 210000000214 mouth Anatomy 0.000 description 8
• 229940097496 nasal spray Drugs 0.000 description 8
• 235000015097 nutrients Nutrition 0.000 description 8
• 229920001817 Agar Polymers 0.000 description 7
• 101100152731 Arabidopsis thaliana TH2 gene Proteins 0.000 description 7
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 7
• 206010061218 Inflammation Diseases 0.000 description 7
• 241000283984 Rodentia Species 0.000 description 7
• 239000008272 agar Substances 0.000 description 7
• 230000006907 apoptotic process Effects 0.000 description 7
• 235000013601 eggs Nutrition 0.000 description 7
• 235000013305 food Nutrition 0.000 description 7
• 238000010353 genetic engineering Methods 0.000 description 7
• 239000001963 growth medium Substances 0.000 description 7
• 229910052739 hydrogen Inorganic materials 0.000 description 7
• 239000001257 hydrogen Substances 0.000 description 7
• 230000006872 improvement Effects 0.000 description 7
• 238000000338 in vitro Methods 0.000 description 7
• 230000004054 inflammatory process Effects 0.000 description 7
• 210000005007 innate immune system Anatomy 0.000 description 7
• 210000004880 lymph fluid Anatomy 0.000 description 7
• 210000004962 mammalian cell Anatomy 0.000 description 7
• 244000000010 microbial pathogen Species 0.000 description 7
• 235000019799 monosodium phosphate Nutrition 0.000 description 7
• 210000005036 nerve Anatomy 0.000 description 7
• 210000003463 organelle Anatomy 0.000 description 7
• 244000144977 poultry Species 0.000 description 7
• 235000013594 poultry meat Nutrition 0.000 description 7
• 239000000523 sample Substances 0.000 description 7
• 239000011780 sodium chloride Substances 0.000 description 7
• AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 7
• 238000011282 treatment Methods 0.000 description 7
• 230000001960 triggered effect Effects 0.000 description 7
• WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 6
• AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 6
• 208000030507 AIDS Diseases 0.000 description 6
• 241000271566 Aves Species 0.000 description 6
• 101800000592 Capsid protein 3 Proteins 0.000 description 6
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
• PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 6
• 108010001336 Horseradish Peroxidase Proteins 0.000 description 6
• 241000371980 Influenza B virus (B/Shanghai/361/2002) Species 0.000 description 6
• 241000699666 Mus <mouse, genus> Species 0.000 description 6
• 102000005348 Neuraminidase Human genes 0.000 description 6
• 108010006232 Neuraminidase Proteins 0.000 description 6
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 6
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
• 230000009471 action Effects 0.000 description 6
• 230000003044 adaptive effect Effects 0.000 description 6
• 230000003698 anagen phase Effects 0.000 description 6
• 210000004102 animal cell Anatomy 0.000 description 6
• 238000003556 assay Methods 0.000 description 6
• 230000008499 blood brain barrier function Effects 0.000 description 6
• 210000001218 blood-brain barrier Anatomy 0.000 description 6
• 210000005056 cell body Anatomy 0.000 description 6
• 230000008859 change Effects 0.000 description 6
• 229940079593 drug Drugs 0.000 description 6
• 210000002472 endoplasmic reticulum Anatomy 0.000 description 6
• 230000036541 health Effects 0.000 description 6
• 230000009545 invasion Effects 0.000 description 6
• 238000002955 isolation Methods 0.000 description 6
• 150000002632 lipids Chemical class 0.000 description 6
• 210000002751 lymph Anatomy 0.000 description 6
• 210000003928 nasal cavity Anatomy 0.000 description 6
• 210000001331 nose Anatomy 0.000 description 6
• 239000012466 permeate Substances 0.000 description 6
• 239000004033 plastic Substances 0.000 description 6
• 229920003023 plastic Polymers 0.000 description 6
• 230000011664 signaling Effects 0.000 description 6
• 229910000162 sodium phosphate Inorganic materials 0.000 description 6
• 210000000278 spinal cord Anatomy 0.000 description 6
• 230000004936 stimulating effect Effects 0.000 description 6
• 208000037259 Amyloid Plaque Diseases 0.000 description 5
• 208000023275 Autoimmune disease Diseases 0.000 description 5
• 102000000844 Cell Surface Receptors Human genes 0.000 description 5
• 108010001857 Cell Surface Receptors Proteins 0.000 description 5
• 241000287828 Gallus gallus Species 0.000 description 5
• 108010044091 Globulins Proteins 0.000 description 5
• 102000006395 Globulins Human genes 0.000 description 5
• 241000238631 Hexapoda Species 0.000 description 5
• 108091034117 Oligonucleotide Proteins 0.000 description 5
• 210000004241 Th2 cell Anatomy 0.000 description 5
• 239000007983 Tris buffer Substances 0.000 description 5
• 230000003213 activating effect Effects 0.000 description 5
• 210000005006 adaptive immune system Anatomy 0.000 description 5
• 210000004204 blood vessel Anatomy 0.000 description 5
• 235000013330 chicken meat Nutrition 0.000 description 5
• 230000008878 coupling Effects 0.000 description 5
• 238000010168 coupling process Methods 0.000 description 5
• 238000005859 coupling reaction Methods 0.000 description 5
• 238000012258 culturing Methods 0.000 description 5
• OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical group NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 5
• 230000006378 damage Effects 0.000 description 5
• 238000010828 elution Methods 0.000 description 5
• 230000012202 endocytosis Effects 0.000 description 5
• 210000001035 gastrointestinal tract Anatomy 0.000 description 5
• 239000011521 glass Substances 0.000 description 5
• 230000012010 growth Effects 0.000 description 5
• 230000001965 increasing effect Effects 0.000 description 5
• 230000001939 inductive effect Effects 0.000 description 5
• 210000000936 intestine Anatomy 0.000 description 5
• 230000002147 killing effect Effects 0.000 description 5
• 230000000670 limiting effect Effects 0.000 description 5
• 244000144972 livestock Species 0.000 description 5
• 210000004698 lymphocyte Anatomy 0.000 description 5
• 210000003712 lysosome Anatomy 0.000 description 5
• 230000001868 lysosomic effect Effects 0.000 description 5
• 210000004126 nerve fiber Anatomy 0.000 description 5
• 239000002773 nucleotide Substances 0.000 description 5
• 125000003729 nucleotide group Chemical group 0.000 description 5
• 230000036961 partial effect Effects 0.000 description 5
• 102000007863 pattern recognition receptors Human genes 0.000 description 5
• 108010089193 pattern recognition receptors Proteins 0.000 description 5
• 230000002399 phagocytotic effect Effects 0.000 description 5
• 239000000843 powder Substances 0.000 description 5
• 238000003908 quality control method Methods 0.000 description 5
• 210000003491 skin Anatomy 0.000 description 5
• 239000007787 solid Substances 0.000 description 5
• 230000009885 systemic effect Effects 0.000 description 5
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 4
• 238000002965 ELISA Methods 0.000 description 4
• 241000196324 Embryophyta Species 0.000 description 4
• 241000725303 Human immunodeficiency virus Species 0.000 description 4
• 102000004388 Interleukin-4 Human genes 0.000 description 4
• 108090000978 Interleukin-4 Proteins 0.000 description 4
• 229930040373 Paraformaldehyde Natural products 0.000 description 4
• 102000003992 Peroxidases Human genes 0.000 description 4
• 241000288906 Primates Species 0.000 description 4
• 201000003176 Severe Acute Respiratory Syndrome Diseases 0.000 description 4
• 108020004682 Single-Stranded DNA Proteins 0.000 description 4
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
• 102000004142 Trypsin Human genes 0.000 description 4
• 108090000631 Trypsin Proteins 0.000 description 4
• 230000000145 adjuvantlike effect Effects 0.000 description 4
• 125000003277 amino group Chemical group 0.000 description 4
• 239000003242 anti bacterial agent Substances 0.000 description 4
• 230000030741 antigen processing and presentation Effects 0.000 description 4
• 230000014102 antigen processing and presentation of exogenous peptide antigen via MHC class I Effects 0.000 description 4
• 229960002685 biotin Drugs 0.000 description 4
• 235000020958 biotin Nutrition 0.000 description 4
• 239000011616 biotin Substances 0.000 description 4
• 229940022399 cancer vaccine Drugs 0.000 description 4
• 239000000969 carrier Substances 0.000 description 4
• 239000006285 cell suspension Substances 0.000 description 4
• 230000033077 cellular process Effects 0.000 description 4
• 230000009260 cross reactivity Effects 0.000 description 4
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 4
• 230000001934 delay Effects 0.000 description 4
• 239000012149 elution buffer Substances 0.000 description 4
• 238000000684 flow cytometry Methods 0.000 description 4
• 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
• 238000003384 imaging method Methods 0.000 description 4
• 229930027917 kanamycin Natural products 0.000 description 4
• 229960000318 kanamycin Drugs 0.000 description 4
• SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 4
• 229930182823 kanamycin A Natural products 0.000 description 4
• 210000003127 knee Anatomy 0.000 description 4
• 230000021633 leukocyte mediated immunity Effects 0.000 description 4
• 230000003137 locomotive effect Effects 0.000 description 4
• 210000003205 muscle Anatomy 0.000 description 4
• 210000001517 olfactory receptor neuron Anatomy 0.000 description 4
• 229920002866 paraformaldehyde Polymers 0.000 description 4
• XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
• 210000001986 peyer's patch Anatomy 0.000 description 4
• 238000001556 precipitation Methods 0.000 description 4
• 239000002243 precursor Substances 0.000 description 4
• 230000001737 promoting effect Effects 0.000 description 4
• 230000004224 protection Effects 0.000 description 4
• 239000007921 spray Substances 0.000 description 4
• 230000000638 stimulation Effects 0.000 description 4
• 230000001225 therapeutic effect Effects 0.000 description 4
• 238000012546 transfer Methods 0.000 description 4
• 239000012588 trypsin Substances 0.000 description 4
• 229960004854 viral vaccine Drugs 0.000 description 4
• 210000002845 virion Anatomy 0.000 description 4
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
• 241000711573 Coronaviridae Species 0.000 description 3
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
• 102000008070 Interferon-gamma Human genes 0.000 description 3
• 108010074328 Interferon-gamma Proteins 0.000 description 3
• 102000000588 Interleukin-2 Human genes 0.000 description 3
• 108010002350 Interleukin-2 Proteins 0.000 description 3
• 102000000743 Interleukin-5 Human genes 0.000 description 3
• 108010002616 Interleukin-5 Proteins 0.000 description 3
• 102000015696 Interleukins Human genes 0.000 description 3
• 108010063738 Interleukins Proteins 0.000 description 3
• OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
• 229930006000 Sucrose Natural products 0.000 description 3
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
• 208000036142 Viral infection Diseases 0.000 description 3
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
• 239000000654 additive Substances 0.000 description 3
• 230000001464 adherent effect Effects 0.000 description 3
• 230000032683 aging Effects 0.000 description 3
• 208000030961 allergic reaction Diseases 0.000 description 3
• 230000004075 alteration Effects 0.000 description 3
• BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
• 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
• 235000011130 ammonium sulphate Nutrition 0.000 description 3
• 230000003466 anti-cipated effect Effects 0.000 description 3
• 125000004429 atom Chemical group 0.000 description 3
• 230000003115 biocidal effect Effects 0.000 description 3
• 210000001124 body fluid Anatomy 0.000 description 3
• 239000010839 body fluid Substances 0.000 description 3
• 239000001110 calcium chloride Substances 0.000 description 3
• 235000011148 calcium chloride Nutrition 0.000 description 3
• 229910001628 calcium chloride Inorganic materials 0.000 description 3
• 230000034303 cell budding Effects 0.000 description 3
• 210000002421 cell wall Anatomy 0.000 description 3
• 238000004132 cross linking Methods 0.000 description 3
• 230000007123 defense Effects 0.000 description 3
• 230000001419 dependent effect Effects 0.000 description 3
• 239000003623 enhancer Substances 0.000 description 3
• 210000002919 epithelial cell Anatomy 0.000 description 3
• 210000003743 erythrocyte Anatomy 0.000 description 3
• 230000012173 estrus Effects 0.000 description 3
• 239000000834 fixative Substances 0.000 description 3
• 230000037406 food intake Effects 0.000 description 3
• -1 for example Substances 0.000 description 3
• 239000000122 growth hormone Substances 0.000 description 3
• 108091008039 hormone receptors Proteins 0.000 description 3
• 125000004435 hydrogen atom Chemical class [H]* 0.000 description 3
• 230000006450 immune cell response Effects 0.000 description 3
• 230000001900 immune effect Effects 0.000 description 3
• 230000001524 infective effect Effects 0.000 description 3
• 238000002347 injection Methods 0.000 description 3
• 239000007924 injection Substances 0.000 description 3
• 208000014674 injury Diseases 0.000 description 3
• 230000000968 intestinal effect Effects 0.000 description 3
• 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 3
• 201000004792 malaria Diseases 0.000 description 3
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 3
• 239000011976 maleic acid Substances 0.000 description 3
• 239000003550 marker Substances 0.000 description 3
• 230000004048 modification Effects 0.000 description 3
• 238000012986 modification Methods 0.000 description 3
• 210000004940 nucleus Anatomy 0.000 description 3
• 230000035764 nutrition Effects 0.000 description 3
• 235000016709 nutrition Nutrition 0.000 description 3
• 210000000056 organ Anatomy 0.000 description 3
• 239000000047 product Substances 0.000 description 3
• 238000004064 recycling Methods 0.000 description 3
• 230000010076 replication Effects 0.000 description 3
• 208000023504 respiratory system disease Diseases 0.000 description 3
• 108091008146 restriction endonucleases Proteins 0.000 description 3
• 230000007441 retrograde transport Effects 0.000 description 3
• 230000028327 secretion Effects 0.000 description 3
• YEENEYXBHNNNGV-XEHWZWQGSA-M sodium;3-acetamido-5-[acetyl(methyl)amino]-2,4,6-triiodobenzoate;(2r,3r,4s,5s,6r)-2-[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound [Na+].CC(=O)N(C)C1=C(I)C(NC(C)=O)=C(I)C(C([O-])=O)=C1I.O[C@H]1[C@H](O)[C@@H](CO)O[C@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 YEENEYXBHNNNGV-XEHWZWQGSA-M 0.000 description 3
• 239000005720 sucrose Substances 0.000 description 3
• 239000000725 suspension Substances 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
• 230000009466 transformation Effects 0.000 description 3
• 238000002255 vaccination Methods 0.000 description 3
• 230000035899 viability Effects 0.000 description 3
• 230000009385 viral infection Effects 0.000 description 3
• UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 2
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
• 208000007204 Brain death Diseases 0.000 description 2
• 108090000565 Capsid Proteins Proteins 0.000 description 2
• 241000282693 Cercopithecidae Species 0.000 description 2
• 108091026890 Coding region Proteins 0.000 description 2
• 102000016911 Deoxyribonucleases Human genes 0.000 description 2
• 108010053770 Deoxyribonucleases Proteins 0.000 description 2
• 239000012591 Dulbecco’s Phosphate Buffered Saline Substances 0.000 description 2
• 238000012286 ELISA Assay Methods 0.000 description 2
• 108010042407 Endonucleases Proteins 0.000 description 2
• 102000004533 Endonucleases Human genes 0.000 description 2
• 241000709661 Enterovirus Species 0.000 description 2
• 102000009109 Fc receptors Human genes 0.000 description 2
• 108010087819 Fc receptors Proteins 0.000 description 2
• 108010010803 Gelatin Proteins 0.000 description 2
• 102000006771 Gonadotropins Human genes 0.000 description 2
• 108010086677 Gonadotropins Proteins 0.000 description 2
• 108010051696 Growth Hormone Proteins 0.000 description 2
• 101000831496 Homo sapiens Toll-like receptor 3 Proteins 0.000 description 2
• 101000669447 Homo sapiens Toll-like receptor 4 Proteins 0.000 description 2
• 101000669402 Homo sapiens Toll-like receptor 7 Proteins 0.000 description 2
• 101000800483 Homo sapiens Toll-like receptor 8 Proteins 0.000 description 2
• 239000007836 KH2PO4 Substances 0.000 description 2
• 102000018656 Mitogen Receptors Human genes 0.000 description 2
• 108010052006 Mitogen Receptors Proteins 0.000 description 2
• 241001494479 Pecora Species 0.000 description 2
• KHGNFPUMBJSZSM-UHFFFAOYSA-N Perforine Natural products COC1=C2CCC(O)C(CCC(C)(C)O)(OC)C2=NC2=C1C=CO2 KHGNFPUMBJSZSM-UHFFFAOYSA-N 0.000 description 2
• 241000709664 Picornaviridae Species 0.000 description 2
• 206010035664 Pneumonia Diseases 0.000 description 2
• 101710193132 Pre-hexon-linking protein VIII Proteins 0.000 description 2
• 229940124859 Rotavirus vaccine Drugs 0.000 description 2
• 241000315672 SARS coronavirus Species 0.000 description 2
• 229920005654 Sephadex Polymers 0.000 description 2
• 239000012507 Sephadex™ Substances 0.000 description 2
• 102000005157 Somatostatin Human genes 0.000 description 2
• 108010056088 Somatostatin Proteins 0.000 description 2
• 102100038803 Somatotropin Human genes 0.000 description 2
• MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
• 102100024324 Toll-like receptor 3 Human genes 0.000 description 2
• 102100039360 Toll-like receptor 4 Human genes 0.000 description 2
• 102100039390 Toll-like receptor 7 Human genes 0.000 description 2
• 102100033110 Toll-like receptor 8 Human genes 0.000 description 2
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
• 208000027418 Wounds and injury Diseases 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• 239000000443 aerosol Substances 0.000 description 2
• 230000007815 allergy Effects 0.000 description 2
• 230000001093 anti-cancer Effects 0.000 description 2
• 230000001188 anti-phage Effects 0.000 description 2
• 229940088710 antibiotic agent Drugs 0.000 description 2
• 210000000709 aorta Anatomy 0.000 description 2
• 229940031567 attenuated vaccine Drugs 0.000 description 2
• 206010064097 avian influenza Diseases 0.000 description 2
• 210000003050 axon Anatomy 0.000 description 2
• 210000000601 blood cell Anatomy 0.000 description 2
• 230000017531 blood circulation Effects 0.000 description 2
• 239000007853 buffer solution Substances 0.000 description 2
• 238000009566 cancer vaccine Methods 0.000 description 2
• 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
• 210000003855 cell nucleus Anatomy 0.000 description 2
• 230000036755 cellular response Effects 0.000 description 2
• 230000004700 cellular uptake Effects 0.000 description 2
• 210000003169 central nervous system Anatomy 0.000 description 2
• 239000000919 ceramic Substances 0.000 description 2
• 230000002490 cerebral effect Effects 0.000 description 2
• 210000000349 chromosome Anatomy 0.000 description 2
• 238000003776 cleavage reaction Methods 0.000 description 2
• 230000000295 complement effect Effects 0.000 description 2
• 102000006834 complement receptors Human genes 0.000 description 2
• 108010047295 complement receptors Proteins 0.000 description 2
• 230000000139 costimulatory effect Effects 0.000 description 2
• 231100000433 cytotoxic Toxicity 0.000 description 2
• 230000001472 cytotoxic effect Effects 0.000 description 2
• 238000013461 design Methods 0.000 description 2
• 230000001079 digestive effect Effects 0.000 description 2
• 102000038379 digestive enzymes Human genes 0.000 description 2
• 108091007734 digestive enzymes Proteins 0.000 description 2
• 238000010790 dilution Methods 0.000 description 2
• 239000012895 dilution Substances 0.000 description 2
• ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
• 235000019797 dipotassium phosphate Nutrition 0.000 description 2
• 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 229920001971 elastomer Polymers 0.000 description 2
• 206010014599 encephalitis Diseases 0.000 description 2
• 210000001163 endosome Anatomy 0.000 description 2
• 210000004954 endothelial membrane Anatomy 0.000 description 2
• 239000002158 endotoxin Substances 0.000 description 2
• 210000001339 epidermal cell Anatomy 0.000 description 2
• 238000011156 evaluation Methods 0.000 description 2
• 210000003608 fece Anatomy 0.000 description 2
• 210000003495 flagella Anatomy 0.000 description 2
• GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
• 239000007850 fluorescent dye Substances 0.000 description 2
• 239000012595 freezing medium Substances 0.000 description 2
• 239000012737 fresh medium Substances 0.000 description 2
• 229940044627 gamma-interferon Drugs 0.000 description 2
• 239000008273 gelatin Substances 0.000 description 2
• 229920000159 gelatin Polymers 0.000 description 2
• 235000019322 gelatine Nutrition 0.000 description 2
• 235000011852 gelatine desserts Nutrition 0.000 description 2
• 102000054767 gene variant Human genes 0.000 description 2
• ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
• 239000002622 gonadotropin Substances 0.000 description 2
• 150000002357 guanidines Chemical class 0.000 description 2
• 210000004837 gut-associated lymphoid tissue Anatomy 0.000 description 2
• BCQZXOMGPXTTIC-UHFFFAOYSA-N halothane Chemical compound FC(F)(F)C(Cl)Br BCQZXOMGPXTTIC-UHFFFAOYSA-N 0.000 description 2
• 229960003132 halothane Drugs 0.000 description 2
• 210000002216 heart Anatomy 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 230000008105 immune reaction Effects 0.000 description 2
• 230000002163 immunogen Effects 0.000 description 2
• 230000002757 inflammatory effect Effects 0.000 description 2
• 229960003971 influenza vaccine Drugs 0.000 description 2
• 230000002401 inhibitory effect Effects 0.000 description 2
• 230000000977 initiatory effect Effects 0.000 description 2
• 238000011081 inoculation Methods 0.000 description 2
• 229940028885 interleukin-4 Drugs 0.000 description 2
• 229940100602 interleukin-5 Drugs 0.000 description 2
• 229940047122 interleukins Drugs 0.000 description 2
• 150000002540 isothiocyanates Chemical class 0.000 description 2
• 230000002045 lasting effect Effects 0.000 description 2
• 210000002414 leg Anatomy 0.000 description 2
• 231100000518 lethal Toxicity 0.000 description 2
• 230000001665 lethal effect Effects 0.000 description 2
• 230000033001 locomotion Effects 0.000 description 2
• 210000005004 lymphoid follicle Anatomy 0.000 description 2
• 239000011159 matrix material Substances 0.000 description 2
• 230000035800 maturation Effects 0.000 description 2
• 235000013372 meat Nutrition 0.000 description 2
• 210000001806 memory b lymphocyte Anatomy 0.000 description 2
• 108020004999 messenger RNA Proteins 0.000 description 2
• 229910052751 metal Inorganic materials 0.000 description 2
• 239000002184 metal Substances 0.000 description 2
• 150000002739 metals Chemical class 0.000 description 2
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
• 230000003641 microbiacidal effect Effects 0.000 description 2
• 239000011859 microparticle Substances 0.000 description 2
• 210000000110 microvilli Anatomy 0.000 description 2
• 230000003278 mimic effect Effects 0.000 description 2
• 239000003595 mist Substances 0.000 description 2
• 230000002438 mitochondrial effect Effects 0.000 description 2
• 238000012544 monitoring process Methods 0.000 description 2
• 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
• 235000019796 monopotassium phosphate Nutrition 0.000 description 2
• 238000002703 mutagenesis Methods 0.000 description 2
• 231100000350 mutagenesis Toxicity 0.000 description 2
• 230000035772 mutation Effects 0.000 description 2
• 230000004770 neurodegeneration Effects 0.000 description 2
• 208000015122 neurodegenerative disease Diseases 0.000 description 2
• 210000004498 neuroglial cell Anatomy 0.000 description 2
• 229910052757 nitrogen Inorganic materials 0.000 description 2
• 108010011903 peptide receptors Proteins 0.000 description 2
• 229930192851 perforin Natural products 0.000 description 2
• 230000035479 physiological effects, processes and functions Effects 0.000 description 2
• 230000008884 pinocytosis Effects 0.000 description 2
• 230000001323 posttranslational effect Effects 0.000 description 2
• GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
• 230000012846 protein folding Effects 0.000 description 2
• 230000005180 public health Effects 0.000 description 2
• 238000002708 random mutagenesis Methods 0.000 description 2
• 230000002829 reductive effect Effects 0.000 description 2
• 230000011514 reflex Effects 0.000 description 2
• 230000019254 respiratory burst Effects 0.000 description 2
• 230000002441 reversible effect Effects 0.000 description 2
• 210000004116 schwann cell Anatomy 0.000 description 2
• 230000007017 scission Effects 0.000 description 2
• 230000003248 secreting effect Effects 0.000 description 2
• 238000012163 sequencing technique Methods 0.000 description 2
• 229910052709 silver Inorganic materials 0.000 description 2
• 239000004332 silver Substances 0.000 description 2
• 210000000813 small intestine Anatomy 0.000 description 2
• 150000003384 small molecules Chemical class 0.000 description 2
• 235000017557 sodium bicarbonate Nutrition 0.000 description 2
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
• NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 description 2
• 229960000553 somatostatin Drugs 0.000 description 2
• 239000007858 starting material Substances 0.000 description 2
• 238000003756 stirring Methods 0.000 description 2
• 210000002784 stomach Anatomy 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 125000001424 substituent group Chemical group 0.000 description 2
• 239000000758 substrate Substances 0.000 description 2
• 239000013589 supplement Substances 0.000 description 2
• 239000002344 surface layer Substances 0.000 description 2
• 230000002459 sustained effect Effects 0.000 description 2
• 230000009747 swallowing Effects 0.000 description 2
• 230000002195 synergetic effect Effects 0.000 description 2
• 230000036962 time dependent Effects 0.000 description 2
• 238000003325 tomography Methods 0.000 description 2
• 229940031418 trivalent vaccine Drugs 0.000 description 2
• 201000008827 tuberculosis Diseases 0.000 description 2
• 241000701161 unidentified adenovirus Species 0.000 description 2
• 241000712461 unidentified influenza virus Species 0.000 description 2
• 241001430294 unidentified retrovirus Species 0.000 description 2
• 238000011144 upstream manufacturing Methods 0.000 description 2
• 238000005406 washing Methods 0.000 description 2
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
• MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 description 1
• RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
• UCTWMZQNUQWSLP-UHFFFAOYSA-N Adrenaline Natural products CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 1
• 206010067484 Adverse reaction Diseases 0.000 description 1
• 208000007848 Alcoholism Diseases 0.000 description 1
• 244000144927 Aloe barbadensis Species 0.000 description 1
• 235000002961 Aloe barbadensis Nutrition 0.000 description 1
• 241000224489 Amoeba Species 0.000 description 1
• 206010002091 Anaesthesia Diseases 0.000 description 1
• 241000711404 Avian avulavirus 1 Species 0.000 description 1
• 108090001008 Avidin Proteins 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 208000014644 Brain disease Diseases 0.000 description 1
• 210000001239 CD8-positive, alpha-beta cytotoxic T lymphocyte Anatomy 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 241000282472 Canis lupus familiaris Species 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
• 102000014914 Carrier Proteins Human genes 0.000 description 1
• 108010078791 Carrier Proteins Proteins 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 229920001661 Chitosan Polymers 0.000 description 1
• 241000862448 Chlorocebus Species 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 206010009944 Colon cancer Diseases 0.000 description 1
• 206010010071 Coma Diseases 0.000 description 1
• 208000035473 Communicable disease Diseases 0.000 description 1
• 241000938605 Crocodylia Species 0.000 description 1
• 201000007336 Cryptococcosis Diseases 0.000 description 1
• 241001337994 Cryptococcus <scale insect> Species 0.000 description 1
• 241000221204 Cryptococcus neoformans Species 0.000 description 1
• 229920000858 Cyclodextrin Polymers 0.000 description 1
• 102100030497 Cytochrome c Human genes 0.000 description 1
• 108010075031 Cytochromes c Proteins 0.000 description 1
• 206010050685 Cytokine storm Diseases 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• 230000006820 DNA synthesis Effects 0.000 description 1
• 238000011238 DNA vaccination Methods 0.000 description 1
• 230000004568 DNA-binding Effects 0.000 description 1
• 206010012289 Dementia Diseases 0.000 description 1
• 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
• 241000255582 Drosophilidae Species 0.000 description 1
• 206010013654 Drug abuse Diseases 0.000 description 1
• 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 1
• 241001115402 Ebolavirus Species 0.000 description 1
• 208000017701 Endocrine disease Diseases 0.000 description 1
• 241001524679 Escherichia virus M13 Species 0.000 description 1
• 108091029865 Exogenous DNA Proteins 0.000 description 1
• 241000282326 Felis catus Species 0.000 description 1
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
• 102000012673 Follicle Stimulating Hormone Human genes 0.000 description 1
• 108010079345 Follicle Stimulating Hormone Proteins 0.000 description 1
• 241000233866 Fungi Species 0.000 description 1
• 241000708493 Gelina Species 0.000 description 1
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
• 102100036263 Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Human genes 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
• 208000010496 Heart Arrest Diseases 0.000 description 1
• HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
• 102000008949 Histocompatibility Antigens Class I Human genes 0.000 description 1
• 108010088652 Histocompatibility Antigens Class I Proteins 0.000 description 1
• 102000018713 Histocompatibility Antigens Class II Human genes 0.000 description 1
• 108010027412 Histocompatibility Antigens Class II Proteins 0.000 description 1
• 101001001786 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Proteins 0.000 description 1
• 101000763579 Homo sapiens Toll-like receptor 1 Proteins 0.000 description 1
• 101000763537 Homo sapiens Toll-like receptor 10 Proteins 0.000 description 1
• 101000831567 Homo sapiens Toll-like receptor 2 Proteins 0.000 description 1
• 101000669460 Homo sapiens Toll-like receptor 5 Proteins 0.000 description 1
• 101000669406 Homo sapiens Toll-like receptor 6 Proteins 0.000 description 1
• 101001082397 Human adenovirus B serotype 3 Hexon-associated protein Proteins 0.000 description 1
• 101001057744 Human cytomegalovirus (strain AD169) Uncharacterized protein IRL9 Proteins 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• 102000004157 Hydrolases Human genes 0.000 description 1
• 108090000604 Hydrolases Proteins 0.000 description 1
• 206010062767 Hypophysitis Diseases 0.000 description 1
• 108060003951 Immunoglobulin Proteins 0.000 description 1
• 102000000589 Interleukin-1 Human genes 0.000 description 1
• 108010002352 Interleukin-1 Proteins 0.000 description 1
• 102000003814 Interleukin-10 Human genes 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 239000000232 Lipid Bilayer Substances 0.000 description 1
• 108090001030 Lipoproteins Proteins 0.000 description 1
• 102000004895 Lipoproteins Human genes 0.000 description 1
• 239000006142 Luria-Bertani Agar Substances 0.000 description 1
• 102000009151 Luteinizing Hormone Human genes 0.000 description 1
• 108010073521 Luteinizing Hormone Proteins 0.000 description 1
• 108010074338 Lymphokines Proteins 0.000 description 1
• 102000008072 Lymphokines Human genes 0.000 description 1
• 239000007993 MOPS buffer Substances 0.000 description 1
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 1
• 241001115401 Marburgvirus Species 0.000 description 1
• 201000005505 Measles Diseases 0.000 description 1
• 241000712079 Measles morbillivirus Species 0.000 description 1
• 241000351643 Metapneumovirus Species 0.000 description 1
• 102000007474 Multiprotein Complexes Human genes 0.000 description 1
• 108010085220 Multiprotein Complexes Proteins 0.000 description 1
• 241000711386 Mumps virus Species 0.000 description 1
• 241000711408 Murine respirovirus Species 0.000 description 1
• 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
• 102000006386 Myelin Proteins Human genes 0.000 description 1
• 108010083674 Myelin Proteins Proteins 0.000 description 1
• 108010025020 Nerve Growth Factor Proteins 0.000 description 1
• 102000015336 Nerve Growth Factor Human genes 0.000 description 1
• 239000000020 Nitrocellulose Substances 0.000 description 1
• 206010030113 Oedema Diseases 0.000 description 1
• 241000283973 Oryctolagus cuniculus Species 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 241000282579 Pan Species 0.000 description 1
• 241001631646 Papillomaviridae Species 0.000 description 1
• 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 241001325166 Phacelia congesta Species 0.000 description 1
• 241000312117 Phago Species 0.000 description 1
• 241000286209 Phasianidae Species 0.000 description 1
• 241000320996 Poeta Species 0.000 description 1
• 208000000474 Poliomyelitis Diseases 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 108010067787 Proteoglycans Proteins 0.000 description 1
• 102000016611 Proteoglycans Human genes 0.000 description 1
• 101001120093 Pseudoalteromonas phage PM2 Protein P8 Proteins 0.000 description 1
• 239000012980 RPMI-1640 medium Substances 0.000 description 1
• 241000711798 Rabies lyssavirus Species 0.000 description 1
• 206010039203 Road traffic accident Diseases 0.000 description 1
• 108091006629 SLC13A2 Proteins 0.000 description 1
• 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
• 241001515849 Satellite Viruses Species 0.000 description 1
• 108091081021 Sense strand Proteins 0.000 description 1
• 229920002684 Sepharose Polymers 0.000 description 1
• 241000191967 Staphylococcus aureus Species 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 241000194048 Streptococcus equi Species 0.000 description 1
• 241000193998 Streptococcus pneumoniae Species 0.000 description 1
• 241000282887 Suidae Species 0.000 description 1
• NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
• 102100027010 Toll-like receptor 1 Human genes 0.000 description 1
• 102100027009 Toll-like receptor 10 Human genes 0.000 description 1
• 102100024333 Toll-like receptor 2 Human genes 0.000 description 1
• 102100039357 Toll-like receptor 5 Human genes 0.000 description 1
• 102100039387 Toll-like receptor 6 Human genes 0.000 description 1
• 108091023040 Transcription factor Proteins 0.000 description 1
• 239000007984 Tris EDTA buffer Substances 0.000 description 1
• 229920004890 Triton X-100 Polymers 0.000 description 1
• 239000013504 Triton X-100 Substances 0.000 description 1
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 101150047749 VIII gene Proteins 0.000 description 1
• 241000711975 Vesicular stomatitis virus Species 0.000 description 1
• 108020005202 Viral DNA Proteins 0.000 description 1
• 108020000999 Viral RNA Proteins 0.000 description 1
• 238000005299 abrasion Methods 0.000 description 1
• 238000010521 absorption reaction Methods 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 150000007513 acids Chemical class 0.000 description 1
• 239000013543 active substance Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 230000006978 adaptation Effects 0.000 description 1
• 230000033289 adaptive immune response Effects 0.000 description 1
• 230000004721 adaptive immunity Effects 0.000 description 1
• 238000007792 addition Methods 0.000 description 1
• 230000000996 additive effect Effects 0.000 description 1
• 210000002534 adenoid Anatomy 0.000 description 1
• 229940102884 adrenalin Drugs 0.000 description 1
• 230000002411 adverse Effects 0.000 description 1
• 230000006838 adverse reaction Effects 0.000 description 1
• 239000011543 agarose gel Substances 0.000 description 1
• 244000000022 airborne pathogen Species 0.000 description 1
• 206010001584 alcohol abuse Diseases 0.000 description 1
• 208000025746 alcohol use disease Diseases 0.000 description 1
• 238000011166 aliquoting Methods 0.000 description 1
• 239000003513 alkali Substances 0.000 description 1
• 239000013566 allergen Substances 0.000 description 1
• 235000011399 aloe vera Nutrition 0.000 description 1
• 238000005576 amination reaction Methods 0.000 description 1
• 150000001412 amines Chemical class 0.000 description 1
• 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
• 230000037005 anaesthesia Effects 0.000 description 1
• 239000003674 animal food additive Substances 0.000 description 1
• 230000000844 anti-bacterial effect Effects 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 210000000628 antibody-producing cell Anatomy 0.000 description 1
• 239000004599 antimicrobial Substances 0.000 description 1
• 239000007864 aqueous solution Substances 0.000 description 1
• 230000001363 autoimmune Effects 0.000 description 1
• 230000008335 axon cargo transport Effects 0.000 description 1
• 229960001212 bacterial vaccine Drugs 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 230000009286 beneficial effect Effects 0.000 description 1
• 239000000227 bioadhesive Substances 0.000 description 1
• 230000033228 biological regulation Effects 0.000 description 1
• 230000005540 biological transmission Effects 0.000 description 1
• 238000007413 biotinylation Methods 0.000 description 1
• 230000006287 biotinylation Effects 0.000 description 1
• VYLDEYYOISNGST-UHFFFAOYSA-N bissulfosuccinimidyl suberate Chemical compound O=C1C(S(=O)(=O)O)CC(=O)N1OC(=O)CCCCCCC(=O)ON1C(=O)C(S(O)(=O)=O)CC1=O VYLDEYYOISNGST-UHFFFAOYSA-N 0.000 description 1
• 230000000903 blocking effect Effects 0.000 description 1
• 210000000988 bone and bone Anatomy 0.000 description 1
• 210000004958 brain cell Anatomy 0.000 description 1
• 230000006931 brain damage Effects 0.000 description 1
• 231100000874 brain damage Toxicity 0.000 description 1
• 208000025698 brain inflammatory disease Diseases 0.000 description 1
• 208000029028 brain injury Diseases 0.000 description 1
• RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 229940041514 candida albicans extract Drugs 0.000 description 1
• 229910052799 carbon Inorganic materials 0.000 description 1
• 238000006555 catalytic reaction Methods 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 239000006143 cell culture medium Substances 0.000 description 1
• 230000011748 cell maturation Effects 0.000 description 1
• 229940030156 cell vaccine Drugs 0.000 description 1
• 229910010293 ceramic material Inorganic materials 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 239000003593 chromogenic compound Substances 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 239000011248 coating agent Substances 0.000 description 1
• 238000000576 coating method Methods 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 230000000052 comparative effect Effects 0.000 description 1
• 238000012875 competitive assay Methods 0.000 description 1
• 230000002860 competitive effect Effects 0.000 description 1
• 230000001010 compromised effect Effects 0.000 description 1
• 238000012790 confirmation Methods 0.000 description 1
• 238000010924 continuous production Methods 0.000 description 1
• 239000013068 control sample Substances 0.000 description 1
• 238000012136 culture method Methods 0.000 description 1
• 235000021438 curry Nutrition 0.000 description 1
• 239000002173 cutting fluid Substances 0.000 description 1
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
• 229940097362 cyclodextrins Drugs 0.000 description 1
• 206010052015 cytokine release syndrome Diseases 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 229940104302 cytosine Drugs 0.000 description 1
• 230000001086 cytosolic effect Effects 0.000 description 1
• 230000007402 cytotoxic response Effects 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 231100000517 death Toxicity 0.000 description 1
• 230000007812 deficiency Effects 0.000 description 1
• 230000007850 degeneration Effects 0.000 description 1
• 238000000432 density-gradient centrifugation Methods 0.000 description 1
• 239000007933 dermal patch Substances 0.000 description 1
• 239000000645 desinfectant Substances 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 239000003599 detergent Substances 0.000 description 1
• 230000001627 detrimental effect Effects 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• 235000005911 diet Nutrition 0.000 description 1
• 230000037213 diet Effects 0.000 description 1
• 239000003085 diluting agent Substances 0.000 description 1
• 238000002224 dissection Methods 0.000 description 1
• 238000004090 dissolution Methods 0.000 description 1
• 239000002552 dosage form Substances 0.000 description 1
• 230000035622 drinking Effects 0.000 description 1
• 239000000975 dye Substances 0.000 description 1
• 238000001962 electrophoresis Methods 0.000 description 1
• 239000000839 emulsion Substances 0.000 description 1
• 230000002124 endocrine Effects 0.000 description 1
• 230000007515 enzymatic degradation Effects 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 208000001780 epistaxis Diseases 0.000 description 1
• 210000004955 epithelial membrane Anatomy 0.000 description 1
• 210000003238 esophagus Anatomy 0.000 description 1
• 229940011871 estrogen Drugs 0.000 description 1
• 239000000262 estrogen Substances 0.000 description 1
• 238000012869 ethanol precipitation Methods 0.000 description 1
• 230000010429 evolutionary process Effects 0.000 description 1
• 230000007717 exclusion Effects 0.000 description 1
• 239000013613 expression plasmid Substances 0.000 description 1
• 210000003414 extremity Anatomy 0.000 description 1
• 238000009313 farming Methods 0.000 description 1
• 230000002349 favourable effect Effects 0.000 description 1
• 238000000855 fermentation Methods 0.000 description 1
• 230000004151 fermentation Effects 0.000 description 1
• 238000001914 filtration Methods 0.000 description 1
• 238000013100 final test Methods 0.000 description 1
• 238000007667 floating Methods 0.000 description 1
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
• 238000001215 fluorescent labelling Methods 0.000 description 1
• 229940028334 follicle stimulating hormone Drugs 0.000 description 1
• 244000053095 fungal pathogen Species 0.000 description 1
• 108020001507 fusion proteins Proteins 0.000 description 1
• 102000037865 fusion proteins Human genes 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 230000001279 glycosylating effect Effects 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 230000005484 gravity Effects 0.000 description 1
• 230000036433 growing body Effects 0.000 description 1
• ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
• 125000005843 halogen group Chemical group 0.000 description 1
• 239000002920 hazardous waste Substances 0.000 description 1
• 229960002897 heparin Drugs 0.000 description 1
• 229920000669 heparin Polymers 0.000 description 1
• 238000000265 homogenisation Methods 0.000 description 1
• 230000003054 hormonal effect Effects 0.000 description 1
• 230000008348 humoral response Effects 0.000 description 1
• 230000003301 hydrolyzing effect Effects 0.000 description 1
• 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
• 238000007654 immersion Methods 0.000 description 1
• 230000005934 immune activation Effects 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 102000018358 immunoglobulin Human genes 0.000 description 1
• 230000016784 immunoglobulin production Effects 0.000 description 1
• 238000003364 immunohistochemistry Methods 0.000 description 1
• 238000009169 immunotherapy Methods 0.000 description 1
• 229940031551 inactivated vaccine Drugs 0.000 description 1
• 230000002779 inactivation Effects 0.000 description 1
• 230000015788 innate immune response Effects 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 229940117681 interleukin-12 Drugs 0.000 description 1
• 238000010255 intramuscular injection Methods 0.000 description 1
• 239000007927 intramuscular injection Substances 0.000 description 1
• 238000001990 intravenous administration Methods 0.000 description 1
• 238000010253 intravenous injection Methods 0.000 description 1
• 239000002085 irritant Substances 0.000 description 1
• 231100000021 irritant Toxicity 0.000 description 1
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
• 230000003902 lesion Effects 0.000 description 1
• 229920006008 lipopolysaccharide Polymers 0.000 description 1
• 238000013332 literature search Methods 0.000 description 1
• 210000004185 liver Anatomy 0.000 description 1
• 238000011068 loading method Methods 0.000 description 1
• 210000004072 lung Anatomy 0.000 description 1
• 229940040129 luteinizing hormone Drugs 0.000 description 1
• 230000002934 lysing effect Effects 0.000 description 1
• 235000010335 lysozyme Nutrition 0.000 description 1
• 210000003126 m-cell Anatomy 0.000 description 1
• 238000002595 magnetic resonance imaging Methods 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 201000011475 meningoencephalitis Diseases 0.000 description 1
• 239000002207 metabolite Substances 0.000 description 1
• 229940124561 microbicide Drugs 0.000 description 1
• 244000005700 microbiome Species 0.000 description 1
• 230000002025 microglial effect Effects 0.000 description 1
• 210000001700 mitochondrial membrane Anatomy 0.000 description 1
• 102000035118 modified proteins Human genes 0.000 description 1
• 108091005573 modified proteins Proteins 0.000 description 1
• 238000003032 molecular docking Methods 0.000 description 1
• 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
• 210000004877 mucosa Anatomy 0.000 description 1
• 229940031348 multivalent vaccine Drugs 0.000 description 1
• 230000000869 mutational effect Effects 0.000 description 1
• DAZSWUUAFHBCGE-KRWDZBQOSA-N n-[(2s)-3-methyl-1-oxo-1-pyrrolidin-1-ylbutan-2-yl]-3-phenylpropanamide Chemical compound N([C@@H](C(C)C)C(=O)N1CCCC1)C(=O)CCC1=CC=CC=C1 DAZSWUUAFHBCGE-KRWDZBQOSA-N 0.000 description 1
• 229940053128 nerve growth factor Drugs 0.000 description 1
• 210000000653 nervous system Anatomy 0.000 description 1
• 238000006386 neutralization reaction Methods 0.000 description 1
• 229920001220 nitrocellulos Polymers 0.000 description 1
• 125000004433 nitrogen atom Chemical group N* 0.000 description 1
• KDWFDOFTPHDNJL-TUBOTVQJSA-N odn-2006 Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=S)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)O[C@@H]2[C@H](O[C@H](C2)N2C(NC(=O)C(C)=C2)=O)COP(O)(=O)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=S)O[C@H]2[C@H]([C@@H](O[C@@H]2COP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=C(C(NC(N)=N3)=O)N=C2)OP(S)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C(N=C(N)C=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)OP(O)(=O)OC[C@@H]2[C@H](C[C@@H](O2)N2C(NC(=O)C(C)=C2)=O)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C(N=C(N)C=C2)=O)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C3=C(C(NC(N)=N3)=O)N=C2)O)N2C(N=C(N)C=C2)=O)O)[C@@H](O)C1 KDWFDOFTPHDNJL-TUBOTVQJSA-N 0.000 description 1
• 244000039328 opportunistic pathogen Species 0.000 description 1
• 230000003287 optical effect Effects 0.000 description 1
• 229960005030 other vaccine in atc Drugs 0.000 description 1
• 125000004430 oxygen atom Chemical group O* 0.000 description 1
• 238000004806 packaging method and process Methods 0.000 description 1
• 230000036407 pain Effects 0.000 description 1
• 210000002741 palatine tonsil Anatomy 0.000 description 1
• 230000003076 paracrine Effects 0.000 description 1
• 230000000803 paradoxical effect Effects 0.000 description 1
• 239000013618 particulate matter Substances 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 238000005325 percolation Methods 0.000 description 1
• 230000010412 perfusion Effects 0.000 description 1
• 230000035699 permeability Effects 0.000 description 1
• 108700010839 phage proteins Proteins 0.000 description 1
• 239000002831 pharmacologic agent Substances 0.000 description 1
• 238000002205 phenol-chloroform extraction Methods 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 150000003904 phospholipids Chemical class 0.000 description 1
• 238000000053 physical method Methods 0.000 description 1
• 230000035790 physiological processes and functions Effects 0.000 description 1
• 210000003635 pituitary gland Anatomy 0.000 description 1
• 239000011148 porous material Substances 0.000 description 1
• 239000002244 precipitate Substances 0.000 description 1
• 239000003755 preservative agent Substances 0.000 description 1
• 230000003449 preventive effect Effects 0.000 description 1
• 150000003141 primary amines Chemical group 0.000 description 1
• 230000037452 priming Effects 0.000 description 1
• 230000002035 prolonged effect Effects 0.000 description 1
• 210000004129 prosencephalon Anatomy 0.000 description 1
• 239000011253 protective coating Substances 0.000 description 1
• 239000011241 protective layer Substances 0.000 description 1
• 235000004252 protein component Nutrition 0.000 description 1
• 108091005974 protein filaments Proteins 0.000 description 1
• 102000034272 protein filaments Human genes 0.000 description 1
• 229940023143 protein vaccine Drugs 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 239000000700 radioactive tracer Substances 0.000 description 1
• 230000036647 reaction Effects 0.000 description 1
• 239000011541 reaction mixture Substances 0.000 description 1
• 230000006798 recombination Effects 0.000 description 1
• 238000005215 recombination Methods 0.000 description 1
• 230000007115 recruitment Effects 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• 238000005057 refrigeration Methods 0.000 description 1
• 230000002787 reinforcement Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 230000033458 reproduction Effects 0.000 description 1
• 230000000241 respiratory effect Effects 0.000 description 1
• 230000029058 respiratory gaseous exchange Effects 0.000 description 1
• 210000002345 respiratory system Anatomy 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 238000010839 reverse transcription Methods 0.000 description 1
• 238000011076 safety test Methods 0.000 description 1
• 150000003839 salts Chemical class 0.000 description 1
• 238000005070 sampling Methods 0.000 description 1
• 229920006395 saturated elastomer Polymers 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 230000035938 sexual maturation Effects 0.000 description 1
• 238000007493 shaping process Methods 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 239000002002 slurry Substances 0.000 description 1
• 230000000391 smoking effect Effects 0.000 description 1
• 239000012064 sodium phosphate buffer Substances 0.000 description 1
• XOIQMTLWECTKJL-HXPDMXKUSA-M sodium;(3r,4s)-4-[(2s,5r,7s,8r,9s)-2-[(2r,5s)-5-ethyl-5-[(2r,3s,5r)-5-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate Chemical compound [Na+].C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)C(C)C([O-])=O)O2 XOIQMTLWECTKJL-HXPDMXKUSA-M 0.000 description 1
• 238000000527 sonication Methods 0.000 description 1
• 229960002920 sorbitol Drugs 0.000 description 1
• 238000002798 spectrophotometry method Methods 0.000 description 1
• 238000005507 spraying Methods 0.000 description 1
• 239000003381 stabilizer Substances 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 238000003860 storage Methods 0.000 description 1
• 210000000434 stratum corneum Anatomy 0.000 description 1
• 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 230000035882 stress Effects 0.000 description 1
• 208000011117 substance-related disease Diseases 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 229910052717 sulfur Inorganic materials 0.000 description 1
• 239000011593 sulfur Substances 0.000 description 1
• 230000001502 supplementing effect Effects 0.000 description 1
• 230000008093 supporting effect Effects 0.000 description 1
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 1
• 230000008961 swelling Effects 0.000 description 1
• 210000000225 synapse Anatomy 0.000 description 1
• 230000002194 synthesizing effect Effects 0.000 description 1
• 238000012385 systemic delivery Methods 0.000 description 1
• 229960003604 testosterone Drugs 0.000 description 1
• 229940022511 therapeutic cancer vaccine Drugs 0.000 description 1
• 210000000115 thoracic cavity Anatomy 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 230000007704 transition Effects 0.000 description 1
• 230000005945 translocation Effects 0.000 description 1
• 230000007723 transport mechanism Effects 0.000 description 1
• 230000008733 trauma Effects 0.000 description 1
• 238000001665 trituration Methods 0.000 description 1
• 239000012137 tryptone Substances 0.000 description 1
• 229960001005 tuberculin Drugs 0.000 description 1
• 230000007306 turnover Effects 0.000 description 1
• 230000029069 type 2 immune response Effects 0.000 description 1
• 210000000689 upper leg Anatomy 0.000 description 1
• 229940125575 vaccine candidate Drugs 0.000 description 1
• 229940124856 vaccine component Drugs 0.000 description 1
• 210000001215 vagina Anatomy 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
• 229920002554 vinyl polymer Polymers 0.000 description 1
• 230000029812 viral genome replication Effects 0.000 description 1
• 239000013603 viral vector Substances 0.000 description 1
• 230000000007 visual effect Effects 0.000 description 1
• 238000011179 visual inspection Methods 0.000 description 1
• 210000005253 yeast cell Anatomy 0.000 description 1
• 239000012138 yeast extract Substances 0.000 description 1